BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 11668508)

  • 1. Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.
    Xu Z; Friess H; Solioz M; Aebi S; Korc M; Kleeff J; Büchler MW
    Int J Cancer; 2001 Oct; 94(2):268-74. PubMed ID: 11668508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression.
    Pandita A; Kumar B; Manvati S; Vaishnavi S; Singh SK; Bamezai RN
    PLoS One; 2014; 9(9):e107154. PubMed ID: 25197966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2.
    Morimoto Y; Takada K; Takeuchi O; Watanabe K; Hirohara M; Hamamoto T; Masuda Y
    Mol Cell Biochem; 2020 Sep; 472(1-2):187-198. PubMed ID: 32567031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-X(L) antisense sensitizes human colon cancer cell line to 5-fluorouracil.
    Nita ME; Ono-Nita SK; Tsuno N; Tominaga O; Takenoue T; Sunami E; Kitayama J; Nakamura Y; Nagawa H
    Jpn J Cancer Res; 2000 Aug; 91(8):825-32. PubMed ID: 10965024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X
    Thummuri D; Khan S; Underwood PW; Zhang P; Wiegand J; Zhang X; Budamagunta V; Sobh A; Tagmount A; Loguinov A; Riner AN; Akki AS; Williamson E; Hromas R; Vulpe CD; Zheng G; Trevino JG; Zhou D
    Mol Cancer Ther; 2022 Jan; 21(1):184-192. PubMed ID: 34667112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells.
    Okamoto K; Ocker M; Neureiter D; Dietze O; Zopf S; Hahn EG; Herold C
    J Cell Mol Med; 2007; 11(2):349-61. PubMed ID: 17378914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
    Hoque MM; Iida Y; Kotani H; Harada M
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens.
    Thor Straten P; Andersen MH
    Oncotarget; 2010 Aug; 1(4):239-245. PubMed ID: 21304176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 expression in cell lines breast cancer and death program.
    Janaghard MS; Soleimani S; Movafagh A; Motallebi M; Mousavi SA; Moghadam AAS; Moghadam VE; Khosravi A; Mirzaei HR; Mousavi SAR; Aziziaram Z; Sun C
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):277-285. PubMed ID: 38279418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic DNA nanostructure based on phenotype-specific activation of antisense oligonucleotides.
    Chu LT; Kwong HK; Cui C; Chen TH
    Talanta; 2024 Mar; 269():125399. PubMed ID: 37979506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of C9orf72 sense repeat-targeting antisense oligonucleotides: lessons learned and the path forward.
    Cammack AJ; Balendra R; Isaacs AM
    Brain; 2024 May; ():. PubMed ID: 38805751
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy.
    Dai H; Abdullah R; Wu X; Li F; Ma Y; Lu A; Zhang G
    Front Cell Dev Biol; 2022; 10():855474. PubMed ID: 35652096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer.
    Demeule M; Charfi C; Currie JC; Larocque A; Zgheib A; Kozelko S; Béliveau R; Marsolais C; Annabi B
    Cancer Sci; 2021 Oct; 112(10):4317-4334. PubMed ID: 34314556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway.
    Chang Z; Zhang Y; Liu J; Guan C; Gu X; Yang Z; Ye Q; Ding L; Liu R
    J Oncol; 2019; 2019():9474273. PubMed ID: 31093285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway.
    Li J; Li Y; Meng F; Fu L; Kong C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30042171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions.
    Sasaki N; Ishiwata T; Hasegawa F; Michishita M; Kawai H; Matsuda Y; Arai T; Ishikawa N; Aida J; Takubo K; Toyoda M
    Cancer Sci; 2018 Apr; 109(4):1135-1146. PubMed ID: 29444383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of MicroRNA-15a Contributes to Pathogenesis of Abdominal Aortic Aneurysm (AAA) by Modulating the Expression of Cyclin-Dependent Kinase Inhibitor 2B (CDKN2B).
    Gao P; Si J; Yang B; Yu J
    Med Sci Monit; 2017 Feb; 23():881-888. PubMed ID: 28214350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells.
    Bhagwandin VJ; Bishop JM; Wright WE; Shay JW
    PLoS One; 2016; 11(2):e0148807. PubMed ID: 26859746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Chemotherapy and Potential New Targets in Uterine Leiomyosarcoma.
    Momtahen S; Curtin J; Mittal K
    J Clin Med Res; 2016 Mar; 8(3):181-9. PubMed ID: 26858789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting apoptosis signaling in pancreatic cancer.
    Fulda S
    Cancers (Basel); 2011 Jan; 3(1):241-51. PubMed ID: 24212616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.